RAPT THERAPEUTICS INC's ticker is RAPT and the CUSIP is 75382E109. A total of 88 filers reported holding RAPT THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.25 and the average weighting 1.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $570,132 | -35.7% | 34,304 | -27.6% | 0.00% | – |
| Q2 2023 | $886,380 | -1.0% | 47,400 | -2.9% | 0.00% | – |
| Q1 2023 | $895,572 | -54.7% | 48,805 | -51.1% | 0.00% | -100.0% |
| Q4 2022 | $1,974,931 | +613.0% | 99,744 | +766.2% | 0.00% | – |
| Q3 2022 | $277,000 | +465.3% | 11,515 | +327.9% | 0.00% | – |
| Q2 2022 | $49,000 | -95.0% | 2,691 | -94.0% | 0.00% | – |
| Q1 2022 | $989,000 | -65.5% | 44,962 | -42.4% | 0.00% | -100.0% |
| Q4 2021 | $2,869,000 | +1386.5% | 78,113 | +1153.8% | 0.00% | – |
| Q3 2021 | $193,000 | -1.5% | 6,230 | +0.8% | 0.00% | – |
| Q2 2021 | $196,000 | -1.5% | 6,178 | -31.2% | 0.00% | – |
| Q1 2021 | $199,000 | +24.4% | 8,976 | +10.8% | 0.00% | – |
| Q4 2020 | $160,000 | -74.4% | 8,101 | -58.3% | 0.00% | – |
| Q3 2020 | $626,000 | +38.8% | 19,417 | +24.8% | 0.00% | – |
| Q2 2020 | $451,000 | +1226.5% | 15,564 | +880.1% | 0.00% | – |
| Q1 2020 | $34,000 | -58.0% | 1,588 | -45.9% | 0.00% | – |
| Q4 2019 | $81,000 | – | 2,934 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ponoi Management, LLC | 1,599,417 | $29,189,000 | 46.08% |
| KPCB XV Associates, LLC | 1,297,063 | $23,671,000 | 43.66% |
| Column Group LLC | 2,680,458 | $48,918,000 | 10.41% |
| Ponoi II Management, LLC | 145,401 | $2,654,000 | 7.21% |
| Euclidean Capital LLC | 432,900 | $7,900,000 | 6.72% |
| AJU IB Investment Co., Ltd. | 99,503 | $1,816,000 | 3.52% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,023,321 | $18,676,000 | 3.17% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 443,619 | $8,096,000 | 1.62% |
| Ghost Tree Capital, LLC | 165,000 | $3,011,000 | 1.57% |
| Perceptive Advisors | 1,913,791 | $34,927,000 | 1.09% |